EUVIMEDEUVIMED entdecken
Crossref

Collagen-Based Biomaterials for Cutaneous Repair and Scar Management: From Chronic Wounds to Hypertrophic Scars: Collagen in Skin

Elahe Khademi, Mohammad Reza Nourani

Life Sciences Student Journal · 06.06.2026

DOI: 10.22034/lssj.2025.178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences Student Journal, erschienen am 06.06.2026. Verfasst von Elahe Khademi und 1 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

As the primary structural protein of the cutaneous extracellular matrix, collagen plays a foundational role in orchestrating every phase of the wound healing cascade, making it a critical substrate for advanced biomaterial development.

Objective

This narrative review synthesizes clinical evidence and physiological mechanisms of collagen-based biomaterials—including dressings, bioengineered skin substitutes, and scar therapies—in cutaneous repair.

Methods

High-level evidence was evaluated, focusing on systematic reviews, meta-analyses, and randomized controlled trials (RCTs).

Results

Clinical data strongly support the efficacy of topical collagen dressings, demonstrating accelerated healing trajectories for diabetic foot ulcers (RR 1.69), venous leg ulcers (RR 1.36), and chronic wounds overall (RR 1.44), with collagen-oxidized regenerated cellulose (ORC) matrices showing the highest performance. In deep or severe tissue injuries, acellular dermal regeneration templates (Integra®, Matriderm®) and living bilayered skin equivalents (Apligraf®) markedly enhance anatomical restoration in full-thickness defects and burns. Regarding scar modification, intradermal injectable collagen therapies yield a 50% to 70% volume improvement in atrophic acne scars, while prophylactic application of collagen-GAG matrices mitigates pathological postoperative scar formation. Key translational limitations include high procurement costs, susceptibility to bacterial biofilm degradation, and potential immunogenicity (1% to 3% for bovine derivatives), which are increasingly being bypassed by emerging recombinant human collagen technologies.

Conclusion

Level 1 clinical evidence validates collagen-based biomaterials for chronic wound management, scar prevention, and the structural correction of atrophic deformities. Future breakthroughs are directed toward matrix-metalloproteinase (MMP)-responsive smart hydrogels and genetically personalized scar therapies.

Schlagwörter

collagen-based biomaterialsskin wound healingchronic woundshypertrophic scarsdiabetic foot ulcervenous leg ulcersatrophic acne scarsrecombinant human collagenskin substitutesscar prevention

Zitieren

APA

Khademi, E., & Nourani, M. R. (2026). Collagen-Based Biomaterials for Cutaneous Repair and Scar Management: From Chronic Wounds to Hypertrophic Scars: Collagen in Skin. Life Sciences Student Journal. https://doi.org/10.22034/lssj.2025.178

Vancouver

Khademi E, Nourani MR. Collagen-Based Biomaterials for Cutaneous Repair and Scar Management: From Chronic Wounds to Hypertrophic Scars: Collagen in Skin. Life Sciences Student Journal. 2026. doi:10.22034/lssj.2025.178

BibTeX
@article{Khademi2026,
  author = {Khademi, Elahe and Nourani, Mohammad Reza},
  title = {Collagen-Based Biomaterials for Cutaneous Repair and Scar Management: From Chronic Wounds to Hypertrophic Scars: Collagen in Skin},
  journal = {Life Sciences Student Journal},
  year = {2026},
  doi = {10.22034/lssj.2025.178}
}
Kostenlos starten →